AI in drug discovery: 2025 in review

Pour ceux qui espéraient que l’intelligence artificielle aiderait à fournir des médicaments réellement efficaces, l’espoir perdure. Ici, le Dr Raminderpal Singh revient sur la triste réalité que 2025 a apportée à l’industrie. L’année 2025 restera dans les mémoires comme le moment où la découverte de médicaments contre l’IA est passée de la promesse à la…

Read More

CarGurus (CARG) Valuation Check As New AI Tools And Branding Mark Its Next Phase

CarGurus (CARG) is rolling out a new wave of AI-powered products, including CarGurus Discover, Dealership Mode and PriceVantage, along with updated branding that will be showcased at the 2026 NADA Show. Check out our latest analysis for CarGurus. Despite the excitement over its AI-powered tools and its 20th anniversary, CarGurus’ recent stock price performance has…

Read More

Supply chain resilience and AI readiness start with location-based data

For many supply chain organizations, the resilience conversation has shifted from reacting to disruption to understanding exposure. This shift requires companies to dig deeper, beyond tier-one suppliers, beyond transactional data, and into the physical and geographic realities that shape how goods are purchased, moved and stored over time. The question is no longer whether organizations…

Read More

Enterprises are turning to AI to solve their efficiency problems, but is just a short-term fix?

Michael Kitces and Ben Henry-Moreland ask whether these long-term problems require a solution other than AI? JANUARY 21, 2026 By Ben Henry-Moreland and Michael Kitces As companies grow and merge over time, they accumulate technical debt. Technologies, capabilities, and processes that in a perfect world would be retooled and improved every time the company grows…

Read More